The role of donor-specific HLA alloantibodies in liver transplantation

J. G. O'Leary, A. J. Demetris, L. S. Friedman, H. M. Gebel, P. F. Halloran, A. D. Kirk, S. J. Knechtle, S. V. McDiarmid, A. Shaked, P. I. Terasaki, K. J. Tinckam, S. J. Tomlanovich, K. J. Wood, E. S. Woodle, A. A. Zachary, G. B. Klintmalm

Research output: Contribution to journalArticle

96 Citations (Scopus)

Abstract

The impact of donor-specific HLA alloantibodies (DSA) on short- and long-term liver transplant outcome is not clearly defined. While it is clear that not all levels of allosensitization produce overt clinical injury, and that liver allografts possess some degree of alloantibody resistance, alloantibody-mediated adverse consequences are increasingly being recognized. To better define the current state of this topic, we assembled experts to provide insights, explore controversies and develop recommendations for future research on the consequences of DSA in liver transplantation. This article summarizes the proceedings of this inaugural meeting. Several insights emerged. Acute antibody-mediated rejection (AMR), although rarely diagnosed, is increasingly understood to overlap with T cell-mediated rejection. Isolated liver allograft recipients are at increased risk of early allograft immunologic injury when preformed DSA are high titer and persist posttransplantation. Persons who undergo simultaneous liver-kidney transplantation are at risk of renal AMR when Class II DSA persist posttransplantation. Other under-appreciated DSA associations include ductopenia and fibrosis, plasma cell hepatitis, biliary strictures and accelerated fibrosis associated with recurrent liver disease. Standardized DSA testing and diagnostic criteria for both acute and chronic AMR are needed to distil existing associations into etiological processes in order to develop responsive therapeutic strategies. Assembled experts provide insights, explore controversies, and develop recommendations for future research on the consequences of donor-specific alloantibodies in liver transplantation.

Original languageEnglish (US)
Pages (from-to)779-787
Number of pages9
JournalAmerican Journal of Transplantation
Volume14
Issue number4
DOIs
StatePublished - Jan 1 2014

Fingerprint

Isoantibodies
Liver Transplantation
Allografts
Antibodies
Liver
Fibrosis
Naphazoline
Wounds and Injuries
Plasma Cells
Kidney Transplantation
Hepatitis
Liver Diseases
Pathologic Constriction
T-Lymphocytes
Transplants
Kidney

Keywords

  • Antibody-mediated rejection
  • donor-specific HLA antibodies
  • graft outcomes
  • liver transplant
  • renal transplant
  • simultaneous liver-kidney transplant

ASJC Scopus subject areas

  • Immunology and Allergy
  • Transplantation
  • Pharmacology (medical)

Cite this

O'Leary, J. G., Demetris, A. J., Friedman, L. S., Gebel, H. M., Halloran, P. F., Kirk, A. D., ... Klintmalm, G. B. (2014). The role of donor-specific HLA alloantibodies in liver transplantation. American Journal of Transplantation, 14(4), 779-787. https://doi.org/10.1111/ajt.12667

The role of donor-specific HLA alloantibodies in liver transplantation. / O'Leary, J. G.; Demetris, A. J.; Friedman, L. S.; Gebel, H. M.; Halloran, P. F.; Kirk, A. D.; Knechtle, S. J.; McDiarmid, S. V.; Shaked, A.; Terasaki, P. I.; Tinckam, K. J.; Tomlanovich, S. J.; Wood, K. J.; Woodle, E. S.; Zachary, A. A.; Klintmalm, G. B.

In: American Journal of Transplantation, Vol. 14, No. 4, 01.01.2014, p. 779-787.

Research output: Contribution to journalArticle

O'Leary, JG, Demetris, AJ, Friedman, LS, Gebel, HM, Halloran, PF, Kirk, AD, Knechtle, SJ, McDiarmid, SV, Shaked, A, Terasaki, PI, Tinckam, KJ, Tomlanovich, SJ, Wood, KJ, Woodle, ES, Zachary, AA & Klintmalm, GB 2014, 'The role of donor-specific HLA alloantibodies in liver transplantation', American Journal of Transplantation, vol. 14, no. 4, pp. 779-787. https://doi.org/10.1111/ajt.12667
O'Leary, J. G. ; Demetris, A. J. ; Friedman, L. S. ; Gebel, H. M. ; Halloran, P. F. ; Kirk, A. D. ; Knechtle, S. J. ; McDiarmid, S. V. ; Shaked, A. ; Terasaki, P. I. ; Tinckam, K. J. ; Tomlanovich, S. J. ; Wood, K. J. ; Woodle, E. S. ; Zachary, A. A. ; Klintmalm, G. B. / The role of donor-specific HLA alloantibodies in liver transplantation. In: American Journal of Transplantation. 2014 ; Vol. 14, No. 4. pp. 779-787.
@article{67fceef351f24837928e4e7ff2903d6e,
title = "The role of donor-specific HLA alloantibodies in liver transplantation",
abstract = "The impact of donor-specific HLA alloantibodies (DSA) on short- and long-term liver transplant outcome is not clearly defined. While it is clear that not all levels of allosensitization produce overt clinical injury, and that liver allografts possess some degree of alloantibody resistance, alloantibody-mediated adverse consequences are increasingly being recognized. To better define the current state of this topic, we assembled experts to provide insights, explore controversies and develop recommendations for future research on the consequences of DSA in liver transplantation. This article summarizes the proceedings of this inaugural meeting. Several insights emerged. Acute antibody-mediated rejection (AMR), although rarely diagnosed, is increasingly understood to overlap with T cell-mediated rejection. Isolated liver allograft recipients are at increased risk of early allograft immunologic injury when preformed DSA are high titer and persist posttransplantation. Persons who undergo simultaneous liver-kidney transplantation are at risk of renal AMR when Class II DSA persist posttransplantation. Other under-appreciated DSA associations include ductopenia and fibrosis, plasma cell hepatitis, biliary strictures and accelerated fibrosis associated with recurrent liver disease. Standardized DSA testing and diagnostic criteria for both acute and chronic AMR are needed to distil existing associations into etiological processes in order to develop responsive therapeutic strategies. Assembled experts provide insights, explore controversies, and develop recommendations for future research on the consequences of donor-specific alloantibodies in liver transplantation.",
keywords = "Antibody-mediated rejection, donor-specific HLA antibodies, graft outcomes, liver transplant, renal transplant, simultaneous liver-kidney transplant",
author = "O'Leary, {J. G.} and Demetris, {A. J.} and Friedman, {L. S.} and Gebel, {H. M.} and Halloran, {P. F.} and Kirk, {A. D.} and Knechtle, {S. J.} and McDiarmid, {S. V.} and A. Shaked and Terasaki, {P. I.} and Tinckam, {K. J.} and Tomlanovich, {S. J.} and Wood, {K. J.} and Woodle, {E. S.} and Zachary, {A. A.} and Klintmalm, {G. B.}",
year = "2014",
month = "1",
day = "1",
doi = "10.1111/ajt.12667",
language = "English (US)",
volume = "14",
pages = "779--787",
journal = "American Journal of Transplantation",
issn = "1600-6135",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - The role of donor-specific HLA alloantibodies in liver transplantation

AU - O'Leary, J. G.

AU - Demetris, A. J.

AU - Friedman, L. S.

AU - Gebel, H. M.

AU - Halloran, P. F.

AU - Kirk, A. D.

AU - Knechtle, S. J.

AU - McDiarmid, S. V.

AU - Shaked, A.

AU - Terasaki, P. I.

AU - Tinckam, K. J.

AU - Tomlanovich, S. J.

AU - Wood, K. J.

AU - Woodle, E. S.

AU - Zachary, A. A.

AU - Klintmalm, G. B.

PY - 2014/1/1

Y1 - 2014/1/1

N2 - The impact of donor-specific HLA alloantibodies (DSA) on short- and long-term liver transplant outcome is not clearly defined. While it is clear that not all levels of allosensitization produce overt clinical injury, and that liver allografts possess some degree of alloantibody resistance, alloantibody-mediated adverse consequences are increasingly being recognized. To better define the current state of this topic, we assembled experts to provide insights, explore controversies and develop recommendations for future research on the consequences of DSA in liver transplantation. This article summarizes the proceedings of this inaugural meeting. Several insights emerged. Acute antibody-mediated rejection (AMR), although rarely diagnosed, is increasingly understood to overlap with T cell-mediated rejection. Isolated liver allograft recipients are at increased risk of early allograft immunologic injury when preformed DSA are high titer and persist posttransplantation. Persons who undergo simultaneous liver-kidney transplantation are at risk of renal AMR when Class II DSA persist posttransplantation. Other under-appreciated DSA associations include ductopenia and fibrosis, plasma cell hepatitis, biliary strictures and accelerated fibrosis associated with recurrent liver disease. Standardized DSA testing and diagnostic criteria for both acute and chronic AMR are needed to distil existing associations into etiological processes in order to develop responsive therapeutic strategies. Assembled experts provide insights, explore controversies, and develop recommendations for future research on the consequences of donor-specific alloantibodies in liver transplantation.

AB - The impact of donor-specific HLA alloantibodies (DSA) on short- and long-term liver transplant outcome is not clearly defined. While it is clear that not all levels of allosensitization produce overt clinical injury, and that liver allografts possess some degree of alloantibody resistance, alloantibody-mediated adverse consequences are increasingly being recognized. To better define the current state of this topic, we assembled experts to provide insights, explore controversies and develop recommendations for future research on the consequences of DSA in liver transplantation. This article summarizes the proceedings of this inaugural meeting. Several insights emerged. Acute antibody-mediated rejection (AMR), although rarely diagnosed, is increasingly understood to overlap with T cell-mediated rejection. Isolated liver allograft recipients are at increased risk of early allograft immunologic injury when preformed DSA are high titer and persist posttransplantation. Persons who undergo simultaneous liver-kidney transplantation are at risk of renal AMR when Class II DSA persist posttransplantation. Other under-appreciated DSA associations include ductopenia and fibrosis, plasma cell hepatitis, biliary strictures and accelerated fibrosis associated with recurrent liver disease. Standardized DSA testing and diagnostic criteria for both acute and chronic AMR are needed to distil existing associations into etiological processes in order to develop responsive therapeutic strategies. Assembled experts provide insights, explore controversies, and develop recommendations for future research on the consequences of donor-specific alloantibodies in liver transplantation.

KW - Antibody-mediated rejection

KW - donor-specific HLA antibodies

KW - graft outcomes

KW - liver transplant

KW - renal transplant

KW - simultaneous liver-kidney transplant

UR - http://www.scopus.com/inward/record.url?scp=84897112141&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84897112141&partnerID=8YFLogxK

U2 - 10.1111/ajt.12667

DO - 10.1111/ajt.12667

M3 - Article

VL - 14

SP - 779

EP - 787

JO - American Journal of Transplantation

JF - American Journal of Transplantation

SN - 1600-6135

IS - 4

ER -